semaglutide vs tirzepatide weight loss efficacy VisualAbstract: Superior to in Obese Adults Without Diabetes tirzepatide semaglutide efficacy side effects

The Food and Drug Administrations approval of Wegovy, Novo Nordisks latest obesity drug, for adolescents aged 12 years and older opens up a highly-anticipated tool in the fight against childhood obesity, but some doctors warn the sought-after medication isnt a magic bullet

SNAC creates a temporary alkaline window in the stomach lining to allow absorption

Potential Side Effects Like any medication, tirzepatide may cause side effects, including: Nausea Diarrhea Vomiting Decreased appetite Most side effects are mild and tend to improve as the body adjusts to the medication

Circadian rhythm peak level is noticed at midnight

Inconsistent dosing

There is no solid evidence that GLP-1 meds cause NAION, and the absolute risk if there even is one is so low it barely registers